CN Stock MarketDetailed Quotes

000590 Tus-Pharmaceutical Group

Watchlist
  • 8.73
  • +0.47+5.69%
Not Open Nov 19 15:00 CST
2.09BMarket Cap-218250P/E (TTM)

Tus-Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-21.26%216.23M
-22.83%146.65M
-23.82%77.09M
15.44%404.65M
16.10%274.63M
22.35%190.05M
10.76%101.2M
16.54%350.53M
9.31%236.55M
4.59%155.33M
Operating revenue
-21.26%216.23M
-22.83%146.65M
-23.82%77.09M
15.44%404.65M
16.10%274.63M
22.35%190.05M
10.76%101.2M
16.54%350.53M
9.31%236.55M
4.59%155.33M
Other operating revenue
----
-44.49%1.73M
----
52.93%6.12M
----
114.09%3.11M
----
14.62%4M
----
26.85%1.45M
Total operating cost
-8.72%245.16M
-8.36%168.26M
-9.68%85.67M
17.31%392.81M
20.73%268.57M
25.71%183.61M
21.10%94.85M
24.39%334.86M
23.23%222.46M
20.31%146.06M
Operating cost
-10.67%116.31M
-12.44%77.27M
-19.73%37.95M
12.38%192.53M
13.19%130.21M
18.50%88.25M
9.81%47.28M
27.37%171.33M
19.32%115.03M
15.64%74.47M
Operating tax surcharges
-11.36%5.54M
-5.31%4M
-15.07%1.82M
8.33%8.72M
7.73%6.25M
4.76%4.22M
0.33%2.14M
15.88%8.05M
18.40%5.8M
18.93%4.03M
Operating expense
-25.39%48.32M
-23.35%35.07M
-12.87%19.97M
38.76%89.82M
51.72%64.76M
59.43%45.76M
52.11%22.92M
40.24%64.73M
39.19%42.68M
40.79%28.7M
Administration expense
12.16%63.44M
15.02%44.02M
19.21%22.84M
6.85%86.82M
4.22%56.56M
7.96%38.27M
15.33%19.16M
2.11%81.25M
13.07%54.27M
6.27%35.45M
Financial expense
18.35%1.82M
18.45%1.21M
78.27%549.95K
158.43%2.11M
150.13%1.54M
153.03%1.02M
125.05%308.49K
42.61%-3.6M
41.89%-3.07M
50.66%-1.92M
-Interest expense (Financial expense)
-18.88%2.84M
-21.06%1.92M
-9.35%952.72K
286.52%4.46M
528.10%3.5M
527.10%2.43M
987.63%1.05M
144.75%1.15M
835.11%556.61K
843.16%388.19K
-Interest Income (Financial expense)
42.61%-1.06M
44.78%-748.99K
39.12%-418.23K
34.90%-2.24M
28.41%-1.86M
13.13%-1.36M
24.62%-686.96K
20.82%-3.44M
25.39%-2.59M
42.56%-1.56M
Research and development
5.10%9.73M
9.87%6.69M
-16.54%2.53M
-2.17%12.82M
19.56%9.25M
14.31%6.09M
13.32%3.04M
58.07%13.1M
32.56%7.74M
41.72%5.33M
Credit Impairment Loss
-301.67%-628.61K
-67.42%-712.72K
118.33%826.8
-915.12%-7.96M
89.00%-156.5K
70.64%-425.72K
84.81%-4.51K
894.37%976.26K
-374.12%-1.42M
-470.75%-1.45M
Asset Impairment Loss
--11.24K
--12.65K
----
-616.81%-6.38M
----
----
----
54.64%-890.25K
----
----
Other net revenue
15.01%3.95M
-37.30%1.6M
-19.22%1.56M
18.85%8.32M
-43.20%3.44M
-47.99%2.54M
8.42%1.93M
-35.05%7M
-35.66%6.05M
-25.46%4.89M
Fair value change income
----
----
----
1,648.91%1.9M
----
----
----
-25.59%108.64K
----
----
Invest income
-88.28%71.75K
-105.33%-24.56K
-74.05%89.95K
-66.73%885.86K
-73.68%612.08K
-76.98%461.25K
-39.92%346.63K
-16.31%2.66M
18.06%2.33M
565.65%2M
Asset deal income
-104.11%-6.34K
-99.25%1.26K
----
71,934.05%13.33M
-93.62%154.3K
-93.30%168.51K
3,995.90%149.08K
-96.39%18.5K
356.91%2.42M
433.22%2.52M
Other revenue
59.35%4.5M
-0.92%2.32M
2.08%1.47M
58.65%6.55M
3.57%2.83M
28.37%2.34M
16.37%1.44M
-53.14%4.13M
-57.26%2.73M
-66.23%1.82M
Operating profit
-363.04%-24.97M
-322.78%-20.01M
-184.84%-7.02M
-11.08%20.16M
-52.87%9.49M
-36.56%8.98M
-44.18%8.28M
-46.47%22.67M
-55.52%20.14M
-57.95%14.16M
Add:Non operating Income
95.04%30.68K
28.66%15.92K
936.89%8.72K
25,302.04%9.72M
26.48%15.73K
205.46%12.37K
--840.64
-1.18%38.28K
3.38%12.44K
-43.75%4.05K
Less:Non operating expense
4,325.56%793.57K
28,325.60%671.43K
3,220.73%56.97K
-75.60%203.74K
176.88%17.93K
-61.31%2.36K
164.28%1.72K
50.15%835.14K
-98.36%6.48K
-95.84%6.11K
Total profit
-371.14%-25.74M
-329.82%-20.67M
-185.43%-7.07M
35.67%29.68M
-52.89%9.49M
-36.48%8.99M
-44.18%8.27M
-47.71%21.88M
-55.13%20.15M
-57.78%14.16M
Less:Income tax cost
-14.30%2.5M
2.72%2.61M
-28.11%1.2M
28.07%4.79M
-32.62%2.91M
-1.59%2.54M
-29.80%1.67M
-41.55%3.74M
-25.88%4.33M
-40.56%2.58M
Net profit
-529.26%-28.23M
-460.48%-23.28M
-225.09%-8.27M
37.24%24.89M
-58.43%6.58M
-44.25%6.46M
-46.92%6.61M
-48.82%18.14M
-59.50%15.82M
-60.33%11.58M
Net profit from continuing operation
-529.26%-28.23M
-460.48%-23.28M
-225.09%-8.27M
37.24%24.89M
-58.43%6.58M
-44.25%6.46M
-46.92%6.61M
-48.82%18.14M
-59.50%15.82M
-60.33%11.58M
Less:Minority Profit
50.24%221.02K
58.70%118.19K
-24.71%17.85K
-1,436.47%-356.58K
18.61%147.11K
165.50%74.48K
146.35%23.71K
3,736.94%26.68K
--124.02K
--28.05K
Net profit of parent company owners
-542.52%-28.45M
-466.54%-23.39M
-225.81%-8.28M
39.41%25.25M
-59.04%6.43M
-44.76%6.38M
-47.33%6.58M
-48.90%18.11M
-59.81%15.7M
-60.43%11.55M
Earning per share
Basic earning per share
-541.64%-0.1188
-465.92%-0.0977
-225.82%-0.0346
39.42%0.1054
-58.99%0.0269
-44.61%0.0267
-47.32%0.0275
-48.92%0.0756
-59.78%0.0656
-60.46%0.0482
Diluted earning per share
-541.64%-0.1188
-465.92%-0.0977
-225.82%-0.0346
39.42%0.1054
-58.99%0.0269
-44.61%0.0267
-47.32%0.0275
-48.92%0.0756
-59.78%0.0656
-60.46%0.0482
Other composite income
Total composite income
-529.26%-28.23M
-460.48%-23.28M
-225.09%-8.27M
37.24%24.89M
-58.43%6.58M
-44.25%6.46M
-46.92%6.61M
-48.82%18.14M
-59.50%15.82M
-60.33%11.58M
Total composite income of parent company owners
-542.52%-28.45M
-466.54%-23.39M
-225.81%-8.28M
39.41%25.25M
-59.04%6.43M
-44.76%6.38M
-47.33%6.58M
-48.90%18.11M
-59.81%15.7M
-60.43%11.55M
Total composite income of minority owners
50.24%221.02K
58.70%118.19K
-24.71%17.85K
-1,436.47%-356.58K
18.61%147.11K
165.50%74.48K
146.35%23.71K
3,736.94%26.68K
--124.02K
--28.05K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -21.26%216.23M-22.83%146.65M-23.82%77.09M15.44%404.65M16.10%274.63M22.35%190.05M10.76%101.2M16.54%350.53M9.31%236.55M4.59%155.33M
Operating revenue -21.26%216.23M-22.83%146.65M-23.82%77.09M15.44%404.65M16.10%274.63M22.35%190.05M10.76%101.2M16.54%350.53M9.31%236.55M4.59%155.33M
Other operating revenue -----44.49%1.73M----52.93%6.12M----114.09%3.11M----14.62%4M----26.85%1.45M
Total operating cost -8.72%245.16M-8.36%168.26M-9.68%85.67M17.31%392.81M20.73%268.57M25.71%183.61M21.10%94.85M24.39%334.86M23.23%222.46M20.31%146.06M
Operating cost -10.67%116.31M-12.44%77.27M-19.73%37.95M12.38%192.53M13.19%130.21M18.50%88.25M9.81%47.28M27.37%171.33M19.32%115.03M15.64%74.47M
Operating tax surcharges -11.36%5.54M-5.31%4M-15.07%1.82M8.33%8.72M7.73%6.25M4.76%4.22M0.33%2.14M15.88%8.05M18.40%5.8M18.93%4.03M
Operating expense -25.39%48.32M-23.35%35.07M-12.87%19.97M38.76%89.82M51.72%64.76M59.43%45.76M52.11%22.92M40.24%64.73M39.19%42.68M40.79%28.7M
Administration expense 12.16%63.44M15.02%44.02M19.21%22.84M6.85%86.82M4.22%56.56M7.96%38.27M15.33%19.16M2.11%81.25M13.07%54.27M6.27%35.45M
Financial expense 18.35%1.82M18.45%1.21M78.27%549.95K158.43%2.11M150.13%1.54M153.03%1.02M125.05%308.49K42.61%-3.6M41.89%-3.07M50.66%-1.92M
-Interest expense (Financial expense) -18.88%2.84M-21.06%1.92M-9.35%952.72K286.52%4.46M528.10%3.5M527.10%2.43M987.63%1.05M144.75%1.15M835.11%556.61K843.16%388.19K
-Interest Income (Financial expense) 42.61%-1.06M44.78%-748.99K39.12%-418.23K34.90%-2.24M28.41%-1.86M13.13%-1.36M24.62%-686.96K20.82%-3.44M25.39%-2.59M42.56%-1.56M
Research and development 5.10%9.73M9.87%6.69M-16.54%2.53M-2.17%12.82M19.56%9.25M14.31%6.09M13.32%3.04M58.07%13.1M32.56%7.74M41.72%5.33M
Credit Impairment Loss -301.67%-628.61K-67.42%-712.72K118.33%826.8-915.12%-7.96M89.00%-156.5K70.64%-425.72K84.81%-4.51K894.37%976.26K-374.12%-1.42M-470.75%-1.45M
Asset Impairment Loss --11.24K--12.65K-----616.81%-6.38M------------54.64%-890.25K--------
Other net revenue 15.01%3.95M-37.30%1.6M-19.22%1.56M18.85%8.32M-43.20%3.44M-47.99%2.54M8.42%1.93M-35.05%7M-35.66%6.05M-25.46%4.89M
Fair value change income ------------1,648.91%1.9M-------------25.59%108.64K--------
Invest income -88.28%71.75K-105.33%-24.56K-74.05%89.95K-66.73%885.86K-73.68%612.08K-76.98%461.25K-39.92%346.63K-16.31%2.66M18.06%2.33M565.65%2M
Asset deal income -104.11%-6.34K-99.25%1.26K----71,934.05%13.33M-93.62%154.3K-93.30%168.51K3,995.90%149.08K-96.39%18.5K356.91%2.42M433.22%2.52M
Other revenue 59.35%4.5M-0.92%2.32M2.08%1.47M58.65%6.55M3.57%2.83M28.37%2.34M16.37%1.44M-53.14%4.13M-57.26%2.73M-66.23%1.82M
Operating profit -363.04%-24.97M-322.78%-20.01M-184.84%-7.02M-11.08%20.16M-52.87%9.49M-36.56%8.98M-44.18%8.28M-46.47%22.67M-55.52%20.14M-57.95%14.16M
Add:Non operating Income 95.04%30.68K28.66%15.92K936.89%8.72K25,302.04%9.72M26.48%15.73K205.46%12.37K--840.64-1.18%38.28K3.38%12.44K-43.75%4.05K
Less:Non operating expense 4,325.56%793.57K28,325.60%671.43K3,220.73%56.97K-75.60%203.74K176.88%17.93K-61.31%2.36K164.28%1.72K50.15%835.14K-98.36%6.48K-95.84%6.11K
Total profit -371.14%-25.74M-329.82%-20.67M-185.43%-7.07M35.67%29.68M-52.89%9.49M-36.48%8.99M-44.18%8.27M-47.71%21.88M-55.13%20.15M-57.78%14.16M
Less:Income tax cost -14.30%2.5M2.72%2.61M-28.11%1.2M28.07%4.79M-32.62%2.91M-1.59%2.54M-29.80%1.67M-41.55%3.74M-25.88%4.33M-40.56%2.58M
Net profit -529.26%-28.23M-460.48%-23.28M-225.09%-8.27M37.24%24.89M-58.43%6.58M-44.25%6.46M-46.92%6.61M-48.82%18.14M-59.50%15.82M-60.33%11.58M
Net profit from continuing operation -529.26%-28.23M-460.48%-23.28M-225.09%-8.27M37.24%24.89M-58.43%6.58M-44.25%6.46M-46.92%6.61M-48.82%18.14M-59.50%15.82M-60.33%11.58M
Less:Minority Profit 50.24%221.02K58.70%118.19K-24.71%17.85K-1,436.47%-356.58K18.61%147.11K165.50%74.48K146.35%23.71K3,736.94%26.68K--124.02K--28.05K
Net profit of parent company owners -542.52%-28.45M-466.54%-23.39M-225.81%-8.28M39.41%25.25M-59.04%6.43M-44.76%6.38M-47.33%6.58M-48.90%18.11M-59.81%15.7M-60.43%11.55M
Earning per share
Basic earning per share -541.64%-0.1188-465.92%-0.0977-225.82%-0.034639.42%0.1054-58.99%0.0269-44.61%0.0267-47.32%0.0275-48.92%0.0756-59.78%0.0656-60.46%0.0482
Diluted earning per share -541.64%-0.1188-465.92%-0.0977-225.82%-0.034639.42%0.1054-58.99%0.0269-44.61%0.0267-47.32%0.0275-48.92%0.0756-59.78%0.0656-60.46%0.0482
Other composite income
Total composite income -529.26%-28.23M-460.48%-23.28M-225.09%-8.27M37.24%24.89M-58.43%6.58M-44.25%6.46M-46.92%6.61M-48.82%18.14M-59.50%15.82M-60.33%11.58M
Total composite income of parent company owners -542.52%-28.45M-466.54%-23.39M-225.81%-8.28M39.41%25.25M-59.04%6.43M-44.76%6.38M-47.33%6.58M-48.90%18.11M-59.81%15.7M-60.43%11.55M
Total composite income of minority owners 50.24%221.02K58.70%118.19K-24.71%17.85K-1,436.47%-356.58K18.61%147.11K165.50%74.48K146.35%23.71K3,736.94%26.68K--124.02K--28.05K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data